191 related articles for article (PubMed ID: 33711907)
1. Early mortality and overall survival in acute promyelocytic leukemia: do real-world data match results of the clinical trials?
Dhakal P; Lyden E; Rajasurya V; Zeidan AM; Chaulagain C; Gundabolu K; Bhatt VR
Leuk Lymphoma; 2021 Aug; 62(8):1949-1957. PubMed ID: 33711907
[TBL] [Abstract][Full Text] [Related]
2. Comorbidity burden and outcomes of older adults with acute promyelocytic leukemia: a National Cancer Database analysis of 2221 patients.
Dhakal P; Lyden E; Joshi U; Pyakuryal A; Loh KP; Klepin H; Bhatt VR
Leuk Lymphoma; 2023 Mar; 64(3):691-697. PubMed ID: 36629003
[TBL] [Abstract][Full Text] [Related]
3. Disparity in Utilization of Multiagent Therapy for Acute Promyelocytic Leukemia in the United States.
Dhakal P; Lyden E; Joshi U; Pyakuryal A; Gundabolu K; Zeidan AM; Loh KP; Fisher AL; Bhatt VR
Clin Lymphoma Myeloma Leuk; 2022 May; 22(5):319-325. PubMed ID: 34852977
[TBL] [Abstract][Full Text] [Related]
4. Outcome of Adolescents and Young Adults Compared With Pediatric Patients With Acute Myeloid and Promyelocytic Leukemia.
Nasir SS; Giri S; Nunnery S; Martin MG
Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):126-132.e1. PubMed ID: 27836483
[TBL] [Abstract][Full Text] [Related]
5. The global problem of early deaths in acute promyelocytic leukemia: A strategy to decrease induction mortality in the most curable leukemia.
Jillella AP; Kota VK
Blood Rev; 2018 Mar; 32(2):89-95. PubMed ID: 29033137
[TBL] [Abstract][Full Text] [Related]
6. Improving Outcomes of Acute Promyelocytic Leukemia in the Current Era: Analysis of the SEER Database.
Guru Murthy GS; Szabo A; Michaelis L; Carlson KS; Runaas L; Abedin S; Atallah E
J Natl Compr Canc Netw; 2020 Feb; 18(2):169-175. PubMed ID: 32023530
[TBL] [Abstract][Full Text] [Related]
7. Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL Group.
Bally C; Fadlallah J; Leverger G; Bertrand Y; Robert A; Baruchel A; Guerci A; Recher C; Raffoux E; Thomas X; Leblanc T; Idres N; Cassinat B; Vey N; Chomienne C; Dombret H; Sanz M; Fenaux P; Adès L
J Clin Oncol; 2012 May; 30(14):1641-6. PubMed ID: 22473162
[TBL] [Abstract][Full Text] [Related]
8. Association of insurance types and outcomes in acute promyelocytic leukemia.
Dhakal P; Joshi U; Lyden E; Pyakuryal A; Gundabolu K; Bhatt VR
Leuk Lymphoma; 2022 Nov; 63(11):2627-2635. PubMed ID: 35737360
[TBL] [Abstract][Full Text] [Related]
9. Impact of sociodemographic factors on early mortality in acute promyelocytic leukemia in the United States: A time-trend analysis.
Jamy OH; Dhir A; Costa LJ; Xavier AC
Cancer; 2022 Jan; 128(2):292-298. PubMed ID: 34495548
[TBL] [Abstract][Full Text] [Related]
10. ABO identical and washed blood transfusions as candidate strategies to reduce early mortality in acute promyelocytic leukemia.
Sahai T; Henrichs K; Refaai M; Heal JM; Kirkley SA; Schmidt AE; Mendler JH; Masel D; Liesveld J; Aquina C; Blumberg N
Leuk Res; 2017 Nov; 62():1-3. PubMed ID: 28963906
[TBL] [Abstract][Full Text] [Related]
11. Management and treatment results in patients with acute promyelocytic leukaemia (APL) not enrolled in clinical trials.
Micol JB; Raffoux E; Boissel N; Lengliné E; Canet E; Daniel MT; Labarthe Ad; Maarek O; Cassinat B; Adès L; Baruchel A; Degos L; Azoulay E; Dombret H
Eur J Cancer; 2014 Apr; 50(6):1159-68. PubMed ID: 24440088
[TBL] [Abstract][Full Text] [Related]
12. Survival of de novo and secondary acute promyelocytic leukemia: a propensity-matched analysis of the SEER database.
Giri S; Pathak R; Martin MG; Bhatt VR
Leuk Lymphoma; 2016 Feb; 57(2):385-391. PubMed ID: 26084205
[TBL] [Abstract][Full Text] [Related]
13. Real-life outcomes of unselected acute promyelocytic leukemia patients: a single-center 14-year experience.
Akcay OF; Yeter HH; Buyukasik Y
Rom J Intern Med; 2020 Sep; 58(3):138-145. PubMed ID: 32452194
[TBL] [Abstract][Full Text] [Related]
14. Practice patterns and real-life outcomes for patients with acute promyelocytic leukemia in the United States.
Bewersdorf JP; Prozora S; Podoltsev NA; Shallis RM; Huntington SF; Neparidze N; Wang R; Zeidan AM; Davidoff AJ
Blood Adv; 2022 Jan; 6(2):376-385. PubMed ID: 34724703
[TBL] [Abstract][Full Text] [Related]
15. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.
Lehmann S; Ravn A; Carlsson L; Antunovic P; Deneberg S; Möllgård L; Derolf AR; Stockelberg D; Tidefelt U; Wahlin A; Wennström L; Höglund M; Juliusson G
Leukemia; 2011 Jul; 25(7):1128-34. PubMed ID: 21502956
[TBL] [Abstract][Full Text] [Related]
16. Management of elderly patients with acute promyelocytic leukemia: progress and problems.
Lengfelder E; Hofmann WK; Nolte F
Ann Hematol; 2013 Sep; 92(9):1181-8. PubMed ID: 23694997
[TBL] [Abstract][Full Text] [Related]
17. Acute promyelocytic leukemia in children and adolescents.
Stein EM; Tallman MS
Acta Haematol; 2014; 132(3-4):307-12. PubMed ID: 25228556
[TBL] [Abstract][Full Text] [Related]
18. Acute promyelocytic leukaemia in children.
Gregory J; Feusner J
Best Pract Res Clin Haematol; 2003 Sep; 16(3):483-94. PubMed ID: 12935964
[TBL] [Abstract][Full Text] [Related]
19. Improvement of Early Death in Acute Promyelocytic Leukemia: A Population-Based Analysis.
Li G; Wu J; Li R; Pan Y; Ma W; Xu J; Nan M; Hou L
Clin Lymphoma Myeloma Leuk; 2023 Feb; 23(2):e78-e84. PubMed ID: 36567214
[TBL] [Abstract][Full Text] [Related]
20. Addressing the room for improvement in management of acute promyelocytic leukemia.
Nørgaard JM; Friis LS; Kristensen JS; Severinsen MT; Mølle I; Marcher CW; Møller P; Schoellkopf C; Nielsen OJ; Preiss BS; Andersen MK; Kjeldsen E; Medeiros BC; Østgård LSG;
Eur J Haematol; 2019 Jun; 102(6):479-485. PubMed ID: 30887583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
